Skip to main content
PMC home page
Applied Microbiology logoLink to Applied Microbiology
. 1971 Jan;21(1):53–60. doi: 10.1128/am.21.1.53-60.1971

Lipoprotein Inhibitor of Newcastle Disease Virus from Chicken Lung

Richard G Allen 1, James T Barrett 1, Benedict J Campbell 1
PMCID: PMC377116  PMID: 4993232

Abstract

A lipoprotein inhibitor of Newcastle disease virus was obtained from chicken lung tissue by means of dilute alkaline extraction procedures. The inhibitor was further purified by ammonium sulfate fractionation, isoelectric precipitation, and density gradient centrifugation. The purified lipoprotein inhibited active Newcastle disease virus hemagglutination at a concentration of 2.0 μg/ml which represented a 30-fold purification over the original extract. Infection of chicken embryo fibroblasts by Newcastle disease virus was also inhibited by the purified lipoprotein, the degree of inhibition depending upon the inhibitor-to-virus ratio. Chemical analysis of the purified inhibitor provided a composition of 72% lipid, 26% protein, and 3% carbohydrate, although some compositional variation was observed from one preparation to another. The chloroform-soluble lipids were shown to contain 40 to 50% phospholipid and 10 to 20% cholesterol; of the fatty acids recovered from the saponified lipoprotein, 39% was palmitic, 22% oleic, and 17% stearic. Careful analyses of large quantities of the inhibitor revealed a small (0.84%) but significant content of sialic acid. Removal of sialic acid from the lipoprotein by means of digestion with neuraminidase produced a sharp diminution in inhibitory properties. A delipidized form of the inhibitor was obtained by ether extraction, and this material produced a single broad band of precipitate in gel immunodiffusion tests.

Full text

PDF
53

Images in this article

56Image
on p.56
58Image
on p.58

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADA G. L., FRENCH E. L., LIND P. E. Purification and properties of neuraminidase from Vibrio cholerae. J Gen Microbiol. 1961 Mar;24:409–425. doi: 10.1099/00221287-24-3-409. [DOI] [PubMed] [Google Scholar]
  2. BARRETT J. T., THOMPSON L. D. IMMUNOCHEMICAL STUDIES WITH CHYMOTRYPSINOGEN A. Immunology. 1965 Feb;8:136–143. [PMC free article] [PubMed] [Google Scholar]
  3. BARTLETT G. R. Phosphorus assay in column chromatography. J Biol Chem. 1959 Mar;234(3):466–468. [PubMed] [Google Scholar]
  4. BIENZ K., LAZARY S., LOEFFLER H. HEMMUNG DER VIRUSHAEMAGGLUTINATION DURCH VIRUSINFIZIERTE UND NICHTINFIZIERTE MAEUSELUNGE. BESCHREIBUNG EINES GEWEBSINHIBITORS. Pathol Microbiol (Basel) 1965;28:151–157. [PubMed] [Google Scholar]
  5. Blumenfeld O. O. The proteins of the erythrocyte membrane obtained by solubilization with aqueous pyridine solution. Biochem Biophys Res Commun. 1968 Jan 25;30(2):200–205. doi: 10.1016/0006-291x(68)90471-3. [DOI] [PubMed] [Google Scholar]
  6. Campbell B. J., Schneider A. L., Howe D. N., Durand D. P. Structural aspects of ovine alpha 1-glycoprotein, an inhibitor of Newcastle disease virus. Biochim Biophys Acta. 1967 Oct 9;148(1):137–145. doi: 10.1016/0304-4165(67)90288-7. [DOI] [PubMed] [Google Scholar]
  7. EAGLE H. Nutrition needs of mammalian cells in tissue culture. Science. 1955 Sep 16;122(3168):501–514. doi: 10.1126/science.122.3168.501. [DOI] [PubMed] [Google Scholar]
  8. Elson L. A., Morgan W. T. A colorimetric method for the determination of glucosamine and chondrosamine. Biochem J. 1933;27(6):1824–1828. doi: 10.1042/bj0271824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. FOLCH J., ASCOLI I., LEES M., MEATH J. A., LeBARON N. Preparation of lipide extracts from brain tissue. J Biol Chem. 1951 Aug;191(2):833–841. [PubMed] [Google Scholar]
  10. FROMMHAGEN L. H., KNIGHT C. A., FREEMAN N. K. The ribonucleic acid, lipid, and polysaccharide constituents of influenza virus preparations. Virology. 1959 Jun;8(2):176–197. doi: 10.1016/0042-6822(59)90003-0. [DOI] [PubMed] [Google Scholar]
  11. Fisher W. R. The characterization and occurrence of an Sf 20 serum lipoprotein. J Biol Chem. 1970 Feb 25;245(4):877–884. [PubMed] [Google Scholar]
  12. Krizanová O., Rathová V. Serum inhibitors of myxoviruses. Curr Top Microbiol Immunol. 1969;47:125–151. doi: 10.1007/978-3-642-46160-6_6. [DOI] [PubMed] [Google Scholar]
  13. LAUCIKOVA O. Enzymatic split product of influenza virus haemagglutination inhibitor. Acta Virol. 1959 Jul;3:139–144. [PubMed] [Google Scholar]
  14. LAUCIKOVA O. Purification and some properties of the inhibitor of virus haemagglutination from chorio-allantoic membranes of the chick embryo. Acta Virol. 1957 Jan-Mar;1(1):2–11. [PubMed] [Google Scholar]
  15. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  16. Leslie G. A., Benedict A. A. Structural and antigenic relationships between avian immunoglobulins. II. Properties of papain- and pepsin-digested chicken, pheasant and quail IgG-immunoglobulins. J Immunol. 1970 Apr;104(4):810–817. [PubMed] [Google Scholar]
  17. Lobodzińska M., Krizanová O. Purification and properties of an influenza virus inhibitor isolated from mouse lungs. Acta Virol. 1966 Jan;10(1):28–34. [PubMed] [Google Scholar]
  18. NEVILLE D. M., Jr The isolation of a cell membrane fraction from rat liver. J Biophys Biochem Cytol. 1960 Oct;8:413–422. doi: 10.1083/jcb.8.2.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. NOLL H., YOUNGNER J. S. Virus-lipid interactions. II. The mechanism of adsorption of lipophilic viruses to water-insoluble polar lipids. Virology. 1959 Jul;8(3):319–343. doi: 10.1016/0042-6822(59)90033-9. [DOI] [PubMed] [Google Scholar]
  20. PHILIPSON L., BENGTSSON S., BRISHAMMAR S., SVENNERHOLM L., ZETTERQVIST O. PURIFICATION AND CHEMICAL ANALYSIS OF THE ERYTHROCYTE RECEPTOR FOR HEMAGGLUTINATING ENTEROVIRUSES. Virology. 1964 Apr;22:580–590. doi: 10.1016/0042-6822(64)90080-7. [DOI] [PubMed] [Google Scholar]
  21. Patton J. F., Platner W. S. Cold acclimation and thyroxine effects on liver and liver mitochondrial fatty acids. Am J Physiol. 1970 May;218(5):1417–1422. doi: 10.1152/ajplegacy.1970.218.5.1417. [DOI] [PubMed] [Google Scholar]
  22. Perdue J. F., Sneider J. The isolation and characterization of the plasma membrane from chick embryo fibroblasts. Biochim Biophys Acta. 1970;196(2):125–140. doi: 10.1016/0005-2736(70)90001-5. [DOI] [PubMed] [Google Scholar]
  23. ROSENBERG A., HOWE C., CHARGAFF E. Inhibition of influenza virus haemagglutination by a brain lipid fraction. Nature. 1956 Feb 4;177(4501):234–235. doi: 10.1038/177234a0. [DOI] [PubMed] [Google Scholar]
  24. SAIFER A., SIEGEL H. A. The photometric determination of the sialic (N-acetylneuraminic) acid distribution in cerebrospinal fluid. J Lab Clin Med. 1959 Mar;53(3):474–483. [PubMed] [Google Scholar]
  25. WARREN L. The thiobarbituric acid assay of sialic acids. J Biol Chem. 1959 Aug;234(8):1971–1975. [PubMed] [Google Scholar]
  26. YOUNGNER J. S., NOLL H. Virus-lipid interactions. I. Concentration and purification of viruses by adsorption to a cholesterol column and studies of the biological properties of lipid-adsorbed virus. Virology. 1958 Aug;6(1):157–180. doi: 10.1016/0042-6822(58)90067-9. [DOI] [PubMed] [Google Scholar]

Articles from Applied Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES